1887

Abstract

Background. Tuberculosis (TB) is a serious public health problem in developing countries such as Pakistan. Rapid diagnosis of TB and detection of drug resistance are very important for timely and appropriate management of multidrug-resistant TB (MDR-TB).

Objective. The purpose of this study was to determine the diagnostic efficacy of the Xpert MTB/RIF assay for rapid diagnosis of TB and detection of rifampicin (RIF) resistance in extrapulmonary and smear-negative pulmonary TB suspects.

Methods. A total of 98 bronchoalveolar lavage fluid (BALF) and 168 extrapulmonary specimens were processed by Xpert MTB/RIF. Culture results are considered as the gold standard for diagnosis of TB, and drug susceptibility testing for detection of RIF resistance. Diagnostic efficacy was measured in terms of sensitivity, specificity and positive and negative predictive values.

Results. The Xpert MTB/RIF assay detected 40 (40.8 %) of 98 BALF of presumptive pulmonary TB and 60 (35.7 %) of 168 extrapulmonary specimens. Sensitivity and specificity of the Xpert MTB/RIF assay for detection of TB was 86 and 88.4 %, respectively. The positive predictive value was 71.5 % while negative predictive value was 95.1 %.

Conclusion. The Xpert MTB/RIF assay is a rapid and simple technique with high sensitivity and specificity for diagnosing TB and detecting drug resistance in extrapulmonary and smear-negative TB cases.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000449
2017-04-28
2019-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/4/412.html?itemId=/content/journal/jmm/10.1099/jmm.0.000449&mimeType=html&fmt=ahah

References

  1. WHO Global Tuberculosis Report 2015 WHO/HTM/TB/2015.22 Geneva: WHO Press; 2015
    [Google Scholar]
  2. WHO Global Tuberculosis Report 2016 2016
    [Google Scholar]
  3. WHO The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis: world health organization. 2010
  4. Young DB, Perkins MD, Duncan K, Barry CE. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest 2008;118:1255–1265 [CrossRef][PubMed]
    [Google Scholar]
  5. Blakemore R, Story E, Helb D, Kop J, Banada P et al. Evaluation of the analytical performance of the xpert MTB/RIF assay. J Clin Microbiol 2010;48:2495–2501 [CrossRef][PubMed]
    [Google Scholar]
  6. Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 2002;40:4435–4438 [CrossRef][PubMed]
    [Google Scholar]
  7. Helb D, Jones M, Story E, Boehme C, Wallace E et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010;48:229–237 [CrossRef][PubMed]
    [Google Scholar]
  8. Huang WL, Chen HY, Kuo YM, Jou R. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2009;47:2520–2524 [CrossRef][PubMed]
    [Google Scholar]
  9. Mani C, Selvakumar N, Narayanan S, Narayanan PR. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol 2001;39:2987–2990 [CrossRef][PubMed]
    [Google Scholar]
  10. WHO Xpert MTB/RIF Implementation Manual Technical and operational ‘how-to’: practical considerations Geneva: WHO; 2014
    [Google Scholar]
  11. Ullah I, Shah AA, Basit A, Ali M, Khan A, Ullah U et al. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study. BMC Infectious Diseases 2016;16:1 [CrossRef]
    [Google Scholar]
  12. WHO Laboratory Services in Tuberculosis Control Part III Culture WHO Geneva, Switzerland: 1998
    [Google Scholar]
  13. Kent PT, Kubica GP, Control CFD. Public health mycobacteriology: a guide for the level III laboratory. US Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1985
  14. Khan MA, Mehreen S, Basit A, Khan RA, Jan F et al. Characteristics and treatment outcomes of patients with multi-drug resistant tuberculosis at a tertiary care hospital in Peshawar, Pakistan. Saudi Med J 2015;36:1463–1471 [CrossRef][PubMed]
    [Google Scholar]
  15. TB India RNTCP Status Report Central TB Division, DGHS 2009
    [Google Scholar]
  16. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969;41:21–43[PubMed]
    [Google Scholar]
  17. Šimundić AM. Measures of diagnostic accuracy: basic definitions. EJIFCC 2009;19:203[PubMed]
    [Google Scholar]
  18. WHO Global Tuberculosis Report 2012 Geneva, Switzerland: WHO; 2012
    [Google Scholar]
  19. WHO World Health Organization Global Tuberculosis Report 2013 Geneva, Switzerland: World Health Organization, WHO Press; 2013
    [Google Scholar]
  20. Cheng VC, Yam WC, Hung IF, Woo PC, Lau SK et al. Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis. J Clin Pathol 2004;57:281–285 [CrossRef][PubMed]
    [Google Scholar]
  21. Ling DI, Flores LL, Riley LW, Pai M. Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS One 2008;3:e1536 [CrossRef][PubMed]
    [Google Scholar]
  22. Greco S, Rulli M, Girardi E, Piersimoni C, Saltini C. Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: meta-analysis and metaregression. J Clin Microbiol 2009;47:569–576 [CrossRef][PubMed]
    [Google Scholar]
  23. Yusuf NW, Iram S, Zeenat A, Hussain S, Aslam M. Rapid diagnosis of tuberculosis using xpert MTB/RIF assay-Report from a developing country. 2014
  24. Baig S, Qayyum S, Saifullah N, Ahmed N. Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin (R) resistance in patients in high risk DRTB. Eur Respir J 2014;44:P2672
    [Google Scholar]
  25. Tadesse M, Abebe G, Abdissa K, Aragaw D, Abdella K et al. GeneXpert MTB/RIF assay for the diagnosis of tuberculous lymphadenitis on concentrated fine needle aspirates in high tuberculosis burden settings. PLoS One 2015;10:e0137471 [CrossRef][PubMed]
    [Google Scholar]
  26. Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M et al. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J 2014;44:435–446 [CrossRef][PubMed]
    [Google Scholar]
  27. Penz E, Boffa J, Roberts DJ, Fisher D, Cooper R et al. Diagnostic accuracy of the xpert® MTB/RIF assay for extra-pulmonary tuberculosis: a meta-analysis. Int J Tuberc Lung Dis 2015;19:278–284 [CrossRef][PubMed]
    [Google Scholar]
  28. Tortoli E, Russo C, Piersimoni C, Mazzola E, dal Monte P et al. Clinical validation of xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012;40:442–447 [CrossRef][PubMed]
    [Google Scholar]
  29. Vassall A, van Kampen S, Sohn H, Michael JS, John KR et al. Rapid diagnosis of tuberculosis with the xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med 2011;8:e1001120 [CrossRef][PubMed]
    [Google Scholar]
  30. Chang K, Lu W, Wang J, Zhang K, Jia S et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with xpert MTB/RIF assay: a meta-analysis. J Infect 2012;64:580–588 [CrossRef][PubMed]
    [Google Scholar]
  31. Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol 2011;49:4138–4141 [CrossRef][PubMed]
    [Google Scholar]
  32. Ligthelm LJ, Nicol MP, Hoek KG, Jacobson R, van Helden PD et al. Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens. J Clin Microbiol 2011;49:3967–3970 [CrossRef][PubMed]
    [Google Scholar]
  33. Al-Ateah SM, Al-Dowaidi MM, El-Khizzi NA. Evaluation of direct detection of Mycobacterium tuberculosis complex in respiratory and non-respiratory clinical specimens using the cepheid gene xpert® system. Saudi Med J 2012;33:1100–1105[PubMed]
    [Google Scholar]
  34. Armand S, Vanhuls P, Delcroix G, Courcol R, Lemaître N. Comparison of the xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 2011;49:1772–1776 [CrossRef][PubMed]
    [Google Scholar]
  35. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005–1015 [CrossRef][PubMed]
    [Google Scholar]
  36. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011;377:1495–1505 [CrossRef][PubMed]
    [Google Scholar]
  37. Marlowe EM, Novak-Weekley SM, Cumpio J, Sharp SE, Momeny MA et al. Evaluation of the cepheid xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 2011;49:1621–1623 [CrossRef][PubMed]
    [Google Scholar]
  38. Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D et al. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?. J Clin Microbiol 2011;49:2540–2545 [CrossRef][PubMed]
    [Google Scholar]
  39. WHO Policy Framework for Implementing TB Diagnostics Geneva: World Health Organization; 2011
    [Google Scholar]
  40. Moure R, Muñoz L, Torres M, Santin M, Martín R et al. Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. J Clin Microbiol 2011;49:1137–1139 [CrossRef][PubMed]
    [Google Scholar]
  41. Javaid A, Hasan R, Zafar A, Ghafoor A, Pathan AJ et al. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan. Int J Tuberc Lung Dis 2008;12:326–331[PubMed]
    [Google Scholar]
  42. Chacón L, Lainez M, Rosales E, Mercado M, Caminero JA. Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua. Int J Tuberc Lung Dis 2009;13:62–67[PubMed]
    [Google Scholar]
  43. Zhao Y, Xu S, Wang L, Chin DP, Wang S et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012;366:2161–2170 [CrossRef][PubMed]
    [Google Scholar]
  44. Luiz RS, Suffys P, Barroso EC, Kerr LR, Duarte CR et al. Genotyping and drug resistance patterns of Mycobacterium tuberculosis strains observed in a tuberculosis high-burden municipality in Northeast, Brazil. Braz J Infect Dis 2013;17:338–345 [CrossRef][PubMed]
    [Google Scholar]
  45. Cohn DL, O'Brien RJ, Geiter LJ, Gordin F, Hershfield E et al. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep 2000;49:1–54
    [Google Scholar]
  46. Yang Y, Zhou C, Shi L, Meng H, Yan H. Prevalence and characterization of drug-resistant tuberculosis in a local hospital of Northeast China. Int J Infect Dis 2014;22:83–86 [CrossRef][PubMed]
    [Google Scholar]
  47. Ejaz M, Siddiqui AR, Rafiq Y, Malik F, Channa A et al. Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: identification of at risk groups. Trans R Soc Trop Med Hyg 2010;104:511–517 [CrossRef][PubMed]
    [Google Scholar]
  48. Yasmin M, Gomgnimbou MK, Siddiqui RT, Refrégier G, Sola C. Multi-drug resistant Mycobacterium tuberculosis complex genetic diversity and clues on recent transmission in Punjab, Pakistan. Infect Genet Evol 2014;27:6–14 [CrossRef][PubMed]
    [Google Scholar]
  49. Ullah I, Javaid A, Tahir Z, Ullah O, Shah AA et al. Pattern of drug resistance and risk factors associated with development of drug resistant Mycobacterium tuberculosis in Pakistan. PLoS One 2016;11:e0147529 [CrossRef][PubMed]
    [Google Scholar]
  50. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects Canary: World Medical Association; 2008
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000449
Loading
/content/journal/jmm/10.1099/jmm.0.000449
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error